Form 8-K - Current report:
SEC Accession No. 0001628280-25-055388
Filing Date
2025-12-04
Accepted
2025-12-04 16:36:38
Documents
23
Period of Report
2025-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrk-20251204.htm   iXBRL 8-K 45470
2 EX-4.1 exhibit41-closing8xk.htm EX-4.1 165582
3 EX-4.2 exhibit42-closing8xk.htm EX-4.2 100239
4 EX-4.3 exhibit43-closing8xk.htm EX-4.3 99117
5 EX-4.4 exhibit44-closing8xk.htm EX-4.4 100907
6 EX-4.5 exhibit45-closing8xk.htm EX-4.5 90149
7 EX-4.6 exhibit46-closing8xk.htm EX-4.6 99914
8 EX-4.7 exhibit47-closing8xk.htm EX-4.7 89674
9 EX-4.8 exhibit48-closing8xk.htm EX-4.8 99151
10 EX-5.1 exhibit51-closing8xk.htm EX-5.1 11089
15 formula.jpg GRAPHIC 12035
  Complete submission text file 0001628280-25-055388.txt   1279826

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20251204.xsd EX-101.SCH 3820
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20251204_def.xml EX-101.DEF 18177
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20251204_lab.xml EX-101.LAB 34044
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20251204_pre.xml EX-101.PRE 19215
25 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20251204_htm.xml XML 8349
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 251550243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)